pfizer glp-1 drug Pfizer's Appetite for More Obesity Meds Leads to $150M Deal for Oral From China Pfizer Accelerates Obesity Pipeline with

It is a cyclic heptapeptide that may engage several melanocortin receptors involved in pigmentation, appetite regulation, and certain neuroendocrine signals

As the bar chart clearly tells us from the 3rd line on the bottom of the graph, obesity leads the top 30 therapy areas by growth from 2022

BPC-157 performs best when the problem is biologically suited to tissue repair: tendon irritation, ligament sprain, muscle strain, fascia irritation, or gut mucosal inflammation

At the same time, it can cause changes in the regulation of intestinal flora, especially an increase of Bacteroides species and decrease of Helicobacter pylori

Apply retinol to the face keeping a margin around the orbital bone

Regulatory review, if trials conclude successfully, could still take several years